Drug Profile
Insulin transdermal - Avecho Biotechnology
Alternative Names: TPM-02/Insulin; TPM/InsulinLatest Information Update: 21 Jan 2022
Price :
$50
*
At a glance
- Originator Phosphagenics
- Class Antihyperglycaemics; Hepatoprotectants; Insulins; Pancreatic hormones
- Mechanism of Action Ornithine decarboxylase stimulants; Phosphokinase stimulants; Protein tyrosine kinase stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- Discontinued Type 1 diabetes mellitus; Type 2 diabetes mellitus